Skip to content
TrackPodcasts
businessApr 24, 202638:23failed

David Sacks, Anthropic, & the White House, Regeneron’s Deafness Cure 4/24/26

Squawk Pod

About this episode

The FDA has approved Regeneron’s gene therapy for a rare form of inherited deafness, and it’s free for Americans. Regeneron CEO Leonard Schleifer discusses the breakthrough treatment, drug pricing, AI’s role in medical innovation, and what breakthroughs might come next. Co-chair of the President’s Council of Advisors on Science and Technology David Sacks was one of the original executives at PayPal, alongside Elon Musk and Peter Thiel. As an AI and crypto advisor to President Trump, the All In Podcast co-host is helping shape AI regulation and policy in the United States. He comments on the government’s complicated relationship with Anthropic and the ongoing feud between Elon Musk and Sam Altman. Plus, a U.S. soldier was arrested for his winning Polymarket bet on the capture of Venezuelan leader Nicolás Maduro, and Intel reported a blowout quarter.

 

David Sacks - 17:43

Leonard Schleifer - 29:21

 

In this episode:

Becky Quick, @BeckyQuick

Joe Kernen, @JoeSquawk

Andrew Ross Sorkin, @andrewrsorkin

Katie Kramer, @Kramer_Katie


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Get every episode summarized

Each time Squawk Pod publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

David Sacks, Anthropic, & the White House, Regeneron’s Deafness Cure 4/24/26

Squawk Pod

0:00
38:23

More episodes

More from Squawk Pod

View all episodes →